Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides
Plain-language summary
This trial is testing ultra-low-dose total skin electron beam radiation therapy for patients with cutaneous T-cell lymphoma (CTCL), including mycosis fungoides or Sézary syndrome at various stages of their disease. This is a Phase 2 trial, which means researchers are studying how well the treatment works and monitoring for side effects. Researchers want to learn whether this approach can help control the lymphoma. This trial is available at 1 location in the United States. The trial is currently recruiting patients.
Who can join (key eligibility)
- Age 18 Years or older
- See full trial listing for complete eligibility
Final eligibility is determined by the trial team. This list is a starting point only.
What's being tested
Quality-of-Life Assessment (OTHER): Ancillary studies | Questionnaire Administration (OTHER): Ancillary studies | Radiation Therapy (RADIATION): Undergo ultra low dose radiation therapy
Quality-of-Life Assessment, Questionnaire Administration, Radiation Therapy
- Treatment length
- Ask the trial team for details
- Visit frequency
- Ask the trial team for details